Intervet/Schering-Plough Animal Health is a global leader in the discovery, development, manufacture and sale of veterinary medicines. The result of the combination of two major companies in the animal health sector, our company offers customers one of the industry's broadest, most innovative portfolios, spanning products to support performance and to prevent, treat and control disease in all major farm and companion animal species.
 
The combination of Intervet and Schering-Plough Animal Health (SPAH) has married two complementary product ranges, strengthening our portfolio and broadening our global reach. We now have offices in more than 50 countries and sell our products in over 140 markets. We operate a network of manufacturing sites and research and development facilities around the world.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough’s vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders served by its approximately 50,000 people around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.